| 초록 |
Progression to end-stage kidney disease (ESKD) from acute kidney injury (AKI) presents challenges due to high comorbidity risks and poor outcomes. This study aimed to develop and validate machine learning survival models for predicting ESKD in patients receiving continuous kidney replacement therapy (CKRT) for AKI. A total of 1,444 AKI patients who survived beyond one week after CKRT were included. Data from six hospitals were used to develop the model, while data from two hospitals formed the validation cohort. A comprehensive set of 122 clinical and laboratory variables was utilized to construct prediction models, including CoxBoost, Elastic-Net Cox, Random Survival Forest, and Cox proportional hazards models. Model performance was assessed using the concordance index (C-index). The CoxBoost model demonstrated superior performance, achieving a C-index of 0.881 (95% confidence interval, 0.756–0.865) in internal validation and 0.742 (0.700–0.788) in external validation. This model reduced the variable set to 23 key parameters, with 24-hour urine output on day 7 of CKRT and pre-existing chronic kidney disease identified as the most critical predictors. A simplified scoring system derived from six binarized variables effectively stratified patients into low-, intermediate-, and high-risk groups for ESKD progression. This machine learning survival approach highlights the importance of specific clinical variables in risk assessment and may aid in personalized interventions and resource allocation to improve outcomes for AKI patients receiving CKRT. |